Overall, that's a pretty damn good quarter given the uncertain healthcare environment and weak hospital budgets. By contrast, St. Jude had a bad miss. This bolds well for when hospitals are back up to full strength.

I would still like a stock buyback program put in place given how poorly the stock has done, especially recently. Hope some research houses re-iterate their BUY recommendations.